Results 131 to 140 of about 18,508 (192)

Two cases of possible transmitted HIV drug resistance to all currently available integrase inhibitors, the Netherlands, 2025. [PDF]

open access: yesEuro Surveill
van Kampen J   +13 more
europepmc   +1 more source

Combined tenofovir, lamivudine, and dolutegravir treatment increases leptin and FABP4 expression in human subcutaneous adipose tissue. [PDF]

open access: yesEinstein (Sao Paulo)
Zanardo LW   +8 more
europepmc   +1 more source

The Epidemiology of HIV-1 Resistance to Two-Drug Regimens in Multicenter Cohort From Poland-A Cross-Sectional Study. [PDF]

open access: yesHealth Sci Rep
Załęski A   +7 more
europepmc   +1 more source

Effectiveness and safety of darunavir and lopinavir for treating children and adolescents living with HIV: a systematic review. [PDF]

open access: yesBMC Infect Dis
O'Rourke J   +10 more
europepmc   +1 more source

Real-World Persistence After Starting Bictegravir- or Dolutegravir-Based Regimens Among Adults Aged ≥50 Years with HIV in the United States. [PDF]

open access: yesDrugs Aging
Kong AM   +9 more
europepmc   +1 more source

Long-Term Effectiveness and Tolerability of Dolutegravir/Lamivudine in Korea: A 3-Year Follow Up Study. [PDF]

open access: yesInfect Chemother
Seong JE   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy